These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37267457)

  • 61. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans.
    Hoffmann D; Brunnemann KD; Prokopczyk B; Djordjevic MV
    J Toxicol Environ Health; 1994 Jan; 41(1):1-52. PubMed ID: 8277523
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Acceptable intakes (AIs) for 11 small molecule N-nitrosamines (NAs).
    Bercu JP; Masuda-Herrera M; Trejo-Martin A; Sura P; Jolly R; Kenyon M; Thomas R; Ponting DJ; Snodin D; Tuschl G; Simon S; De Vlieger K; Hutchinson R; Czich A; Glowienke S; Reddy MV; Johanssen S; Vock E; Claude N; Weaver RJ
    Regul Toxicol Pharmacol; 2023 Aug; 142():105415. PubMed ID: 37257751
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Metabolism and DNA single strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its analogues in primary culture of rat hepatocytes.
    Liu LL; Alaoui-Jamali MA; el Alami N; Castonguay A
    Cancer Res; 1990 Mar; 50(6):1810-6. PubMed ID: 2306734
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The carcinogenic significance of reactive intermediates derived from 3-acetoxy- and 5-acetoxy-2-hydroxy-N-nitrosomorpholine.
    Loeppky RN; Sukhtankar S; Gu F; Park M
    Chem Res Toxicol; 2005 Dec; 18(12):1955-66. PubMed ID: 16359186
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Carcinogenicity tests of acetoxymethylphenylnitrosamine and benzenediazonium tetrafluoroborate in Syrian hamsters.
    Gold B; Salmasi S
    Cancer Lett; 1982; 15(3):289-300. PubMed ID: 7116331
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mutagenicity of alpha-hydroxy N-nitrosamines in V79 Chinese hamster cells.
    Mochizuki M; Osabe M; Anjo T; Suzuki E; Okada M
    J Cancer Res Clin Oncol; 1984; 108(3):290-5. PubMed ID: 6511803
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Predicting DNA-Reactivity of N-Nitrosamines: A Quantum Chemical Approach.
    Wenzel J; Schmidt F; Blumrich M; Amberg A; Czich A
    Chem Res Toxicol; 2022 Nov; 35(11):2068-2084. PubMed ID: 36302168
    [No Abstract]   [Full Text] [Related]  

  • 68. NITROSOGENESIS OF SKIN (HUMAN) CANCER- THE HIDDEN TRUTH OF A NEVERENDING STORY: NITROSAMINE CONTAMINATION IN OLMESARTAN, VALSARTAN AND HCT AS MAIN RISK FACTOR FOR THE DEVELOPMENT OF KERATINOCYTE CANCER.
    Tchernev G; Kordeva S
    Georgian Med News; 2023 Apr; (337):63-67. PubMed ID: 37354675
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The identification of 11 beta-hydroxysteroid dehydrogenase as carbonyl reductase of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
    Maser E; Richter E; Friebertshäuser J
    Eur J Biochem; 1996 Jun; 238(2):484-9. PubMed ID: 8681962
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nitrosamine carcinogenicity: a quantitative Hansch-Taft structure-activity relationship.
    Wishnok JS; Archer MC; Edelman AS; Rand WM
    Chem Biol Interact; 1978 Jan; 20(1):43-54. PubMed ID: 630644
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Influence of amine structural characteristics on N-nitrosamine formation potential relevant to postcombustion CO2 capture systems.
    Dai N; Mitch WA
    Environ Sci Technol; 2013 Nov; 47(22):13175-83. PubMed ID: 24138561
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Critical Analysis of Drug Product Recalls due to Nitrosamine Impurities.
    Bharate SS
    J Med Chem; 2021 Mar; 64(6):2923-2936. PubMed ID: 33706513
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Bumetanide as a Model NDSRI Substrate: N-nitrosobumetanide Impurity Formation and its Inhibition in Bumetanide Tablets.
    Shakleya D; Asmelash B; Alayoubi A; Abrigo N; Mohammad A; Wang J; Zhang J; Yang J; Marzan TA; Li D; Shaklah M; Alsharif FM; Desai S; Faustino PJ; Ashraf M; O'Connor T; Vera M; Raw A; Sayeed VA; Keire D
    J Pharm Sci; 2023 Dec; 112(12):3075-3087. PubMed ID: 37364772
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Assays for metabolic alpha-hydroxylation of N'-nitrosonornicotine and N-nitrosopyrrolidine and the influence of modifying factors.
    Chen CB; Hecht SS; McCoy GD; Hoffmann D
    IARC Sci Publ; 1980; (31):349-59. PubMed ID: 7228264
    [TBL] [Abstract][Full Text] [Related]  

  • 75. What Makes a Potent Nitrosamine? Statistical Validation of Expert-Derived Structure-Activity Relationships.
    Thomas R; Tennant RE; Oliveira AAF; Ponting DJ
    Chem Res Toxicol; 2022 Nov; 35(11):1997-2013. PubMed ID: 36302501
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Regulatory Experiences with Root Causes and Risk Factors for Nitrosamine Impurities in Pharmaceuticals.
    Horne S; Vera MD; Nagavelli LR; Sayeed VA; Heckman L; Johnson D; Berger D; Yip YY; Krahn CL; Sizukusa LO; Rocha NFM; Bream RN; Ludwig J; Keire DA; Condran G
    J Pharm Sci; 2023 May; 112(5):1166-1182. PubMed ID: 36599405
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Absolute Quantitation of
    Wang Q; Liu Z; Liu Y; Chen H
    J Am Soc Mass Spectrom; 2022 May; 33(5):875-884. PubMed ID: 35446584
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Metabolism of 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in primary cultures of rat alveolar type II cells.
    Schrader E; Hirsch-Ernst KI; Scholz E; Kahl GF; Foth H
    Drug Metab Dispos; 2000 Feb; 28(2):180-5. PubMed ID: 10640516
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by hamster respiratory tissues cultured with ellagic acid.
    Castonguay A; Allaire L; Charest M; Rossignol G; Boutet M
    Cancer Lett; 1989 Jul; 46(2):93-105. PubMed ID: 2752387
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparative metabolism of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured F344 rat oral tissue and esophagus.
    Murphy SE; Heiblum R; Trushin N
    Cancer Res; 1990 Aug; 50(15):4685-91. PubMed ID: 2369743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.